Carregant...
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review...
Guardat en:
| Publicat a: | J Int Med Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567749/ https://ncbi.nlm.nih.gov/pubmed/30958071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519837103 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|